ALZI Stock Chart & Stats
$0.33
$0.03(10.00%)
―
--
Day’s Range― - ―
52-Week Range$0.28 - $0.52
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
C$13.91M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.74
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,157,960
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ALZI FAQ
What was Alzai Health Corp.’s price range in the past 12 months?
Alzai Health Corp. lowest stock price was $0.28 and its highest was $0.52 in the past 12 months.
What is Alzai Health Corp.’s market cap?
Alzai Health Corp.’s market cap is C$13.91M.
When is Alzai Health Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alzai Health Corp.’s earnings last quarter?
Currently, no data Available
Is Alzai Health Corp. overvalued?
According to Wall Street analysts Alzai Health Corp.’s price is currently Undervalued.
Does Alzai Health Corp. pay dividends?
Alzai Health Corp. does not currently pay dividends.
What is Alzai Health Corp.’s EPS estimate?
Alzai Health Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alzai Health Corp. have?
Alzai Health Corp. has 42,157,960 shares outstanding.
What happened to Alzai Health Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Alzai Health Corp.?
Currently, no hedge funds are holding shares in TSE:ALZI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Diagnos
―
California Nanotechnologies
―
MedX Health
―
VentriPoint Diagnostics
―
Marvel Biosciences Corp
―